Therapeutic approaches to ion channel diseases (Q34927551)

5 August 2017

1 reference

title

Therapeutic approaches to ion channel diseases (English)

1 reference

5 August 2017

Sabata Pierno

4

0 references

Diana Conte Camerino

object named as

Diana Conte Camerino

series ordinal

1

0 references

Jean-François Desaphy

series ordinal

2

object named as

Jean-François Desaphy

1 reference

5 August 2017

3

Domenico Tricarico

1 reference

5 August 2017

Antonella Liantonio

5

1 reference

5 August 2017

publication date

1 January 2008

1 reference

5 August 2017

1 reference

5 August 2017

volume

64

1 reference

5 August 2017

page(s)

81-145

1 reference

Conformational changes in the pore of CLC-0.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Update in cystic fibrosis 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Neuronal nicotinic receptors: a perspective on two decades of drug discovery research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Prevalence of long-QT syndrome gene variants in sudden infant death syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

From molecule to malady

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Towards a better understanding and new therapeutics of osteopetrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

EFNS guidelines on pharmacological treatment of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Suppression of cortical spreading depression in migraine prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

1 reference

7 January 2021

Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Efficacy of quinidine in high-risk patients with Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Stressed out: the skeletal muscle ryanodine receptor as a target of stress

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Amiloride: a molecular probe of sodium transport in tissues and cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Pharmacological rescue of mutant ion channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

T-lymphocyte interferon-gamma receptor binding in patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Potassium Channel Modulation: Effect of Pinacidil on Insulin Release in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Autoimmune channelopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Disorders of membrane channels or channelopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The chemical biology of clinically tolerated NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Chloride conductance in mouse muscle is subject to post-transcriptional compensation of the functional Cl- channel 1 gene dosage.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Association between genetic variation of CACNA1H and childhood absence epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Voltage-gated sodium channels as therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Prospects for a T-cell receptor vaccination against myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Use of narcotic analgesics in the emergency department treatment of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The effects of taurine on pharmacologically induced myotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Taurine and skeletal muscle disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Ion channel pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The biology of CD20 and its potential as a target for mAb therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Advances in the pathogenesis and treatment of patients with stiff person syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Clinical analysis of anti-Ma2-associated encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Aging and chloride channel regulation in rat fast-twitch muscle fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Optimal requirements for high affinity and use-dependent block of skeletal muscle sodium channel by N-benzyl analogs of tocainide-like compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Genetics, pathogenesis and complications of osteopetrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

1 reference

7 January 2021

Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Pharmacologic management of neuropathic pain: evidence-based recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Acetazolamide acts directly on the human skeletal muscle chloride channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The therapy of congenital myasthenic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

CLC-K channels: if the drug fits, use it.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The P/Q-type voltage-dependent calcium channel: a therapeutic target in spinocerebellar ataxia type 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Inhalation of Moli1901 in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A case of voltage-gated potassium channel antibody-related limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Function and pharmacology of TRPM cation channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Efficacy and safety of varenicline for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The nondystrophic myotonias

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

1 reference

7 January 2021

Channelopathies in idiopathic epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Epithelial Ca2+ and Mg2+ channels in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

K(ATP) channel therapeutics at the bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Activating mutation of the renal epithelial chloride channel ClC-Kb, predisposing to hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

CLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Muscle channelopathies and critical points in functional and genetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Do hyperpolarization-induced proton currents contribute to the pathogenesis of hypokalemic periodic paralysis, a voltage sensor channelopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Anti B cell therapy (rituximab) in the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Bartter syndromes and other salt-losing tubulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular pathogenesis of spinocerebellar ataxia type 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Dantrolene--a review of its pharmacology, therapeutic use and new developments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Lubiprostone: a chloride channel activator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Activation and inhibition of kidney CLC-K chloride channels by fenamates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A common molecular basis for three inherited kidney stone diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Small molecule activator of the human epithelial sodium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

An epilepsy mutation in the beta1 subunit of the voltage-gated sodium channel results in reduced channel sensitivity to phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Hypercalciuria in patients with CLCN5 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

An epidemiological survey of hemiplegic migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mechanisms of action of cyclosporine.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

TRPC6 and FSGS: the latest TRP channelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Hereditary etiologies of hypomagnesemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Bartter's and Gitelman's syndromes: from gene to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

KATP channels as molecular sensors of cellular metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Heterogeneous distribution of chloride channels along the distal convoluted tubule probed by single-cell RT-PCR and patch clamp

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Interactions between taurine and ethanol in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Salt handling and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Propofol restores the function of "hyperekplexic" mutant glycine receptors in Xenopus oocytes and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Development of new antiepileptic drugs: challenges, incentives, and recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular determinants of differential pore blocking of kidney CLC-K chloride channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Blocking sodium channels to treat neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The Elusive Link Between LQT3 and Brugada Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

What's new in cystic fibrosis? From treating symptoms to correction of the basic defect

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Myotonia caused by mutations in the muscle chloride channel gene CLCN1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

K+ channel openers suppress myotonic activity of human skeletal muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

How do mutant Nav1.1 sodium channels cause epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Episodic ataxia type 1: a neuronal potassium channelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Regulation of the human skeletal muscle chloride channel hClC-1 by protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

1 reference

7 January 2021

Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Clinical aspects of MuSK antibody positive seronegative MG.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

hERG potassium channels and cardiac arrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Management and treatment of Andersen-Tawil syndrome (ATS).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Corticosteroids for myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Preventive treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Drugs acting on SUR1 to treat CNS ischemia and trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Genetic mechanisms that underlie epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Episodic ataxia type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Exploration of the basolateral chloride channels in the renal tubule using

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+) -depleted rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Drug treatment for myotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Pixantrone (BBR2778) reduces the severity of experimental autoimmune myasthenia gravis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Bartter's and Gitelman's syndromes: their relationship to the actions of loop and thiazide diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The primary periodic paralyses: diagnosis, pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Challenges in the design and conduct of therapeutic trials in channel disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Autoimmune and paraneoplastic channelopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Invited Article: Autonomic ganglia: target and novel therapeutic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Leflunomide prevents the development of experimentally induced myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Chloride/anion channels in glial cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Pharmacological targeting of long QT mutant sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Preservation of mitochondrial structure and function after cardioplegic arrest in the neonate using a selective mitochondrial KATP channel opener.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Molecular pharmacology of the glycine receptor chloride channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Does modafinil enhance activity of patients with myotonic dystrophy?: a double-blind placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The neuroprotection conferred by activating the mitochondrial ATP-sensitive K+ channel is mediated by inhibiting the mitochondrial permeability transition pore

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel alpha subunit in voltage-dependent gating and drug block.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Rituximab for myasthenia gravis developing after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

A phase I trial of intranasal Moli1901 for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Hyperekplexia: a treatable neurogenetic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

The toxic effects of clofibrate and its metabolite on mammalian skeletal muscle: an electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2808%2900804-3

7 January 2021

RETRACTED: Placebo-controlled comparison of dolasetron and metoclopramide in preventing postoperative nausea and vomiting in patients undergoing hysterectomy

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1046/J.0265-0215.2000.00810.X

Identifiers

DOI

10.1016/S0065-2660(08)00804-3

1 reference

5 August 2017

1 reference